{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:18:50Z","timestamp":1771024730704,"version":"3.50.1"},"reference-count":24,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.3892\/mco.2015.519","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T12:48:44Z","timestamp":1424954924000},"page":"515-521","source":"Crossref","is-referenced-by-count":9,"title":["Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy"],"prefix":"10.3892","volume":"3","author":[{"given":"MAKOTO","family":"KUBO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKEFUMI","family":"SATOH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEN-ICHI","family":"TABATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEYASU","family":"TSUMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASATSUGU","family":"IWAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIRO","family":"BABA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIMOTHY C.","family":"THOMPSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FUMIYA","family":"OBATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"key":"key20180107145041_b1-mco-0-0-519","first-page":"545","article-title":"Patterns of care for carcinoma of the prostate gland: Results of a national survey of 1984 and 1990","volume":"180","author":"Jones","year":"1995","journal-title":"J Am Coll Surg"},{"key":"key20180107145041_b2-mco-0-0-519","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"key":"key20180107145041_b3-mco-0-0-519","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0022-5347(01)66792-2","article-title":"Prognostic significance of positive surgical margins in radical prostatectomy specimens","volume":"154","author":"Ohori","year":"1995","journal-title":"J Urol"},{"key":"key20180107145041_b4-mco-0-0-519","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0090-4295(94)90144-9","article-title":"Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome","volume":"43","author":"Zietman","year":"1994","journal-title":"Urology"},{"key":"key20180107145041_b5-mco-0-0-519","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MOU.0b013e3280e08802","article-title":"Neoadjuvant therapy and prostate cancer: What a urologist should know","volume":"17","author":"Namiki","year":"2007","journal-title":"Curr Opin Urol"},{"key":"key20180107145041_b6-mco-0-0-519","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/10430349950018229","article-title":"In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial","volume":"10","author":"Herman","year":"1999","journal-title":"Hum Gene Ther"},{"key":"key20180107145041_b7-mco-0-0-519","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0022-5347(05)67534-9","article-title":"Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer","volume":"163","author":"Shalev","year":"2000","journal-title":"J Urol"},{"key":"key20180107145041_b8-mco-0-0-519","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1089\/104303401753204535","article-title":"Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy","volume":"12","author":"Miles","year":"2001","journal-title":"Hum Gene Ther"},{"key":"key20180107145041_b9-mco-0-0-519","first-page":"1","article-title":"In situ gene therapy for prostate cancer","volume":"11","author":"Thompson","year":"1999","journal-title":"Oncol Res"},{"key":"key20180107145041_b10-mco-0-0-519","first-page":"5274","article-title":"The \u2018bystander effect\u2019: Tumor regression when a fraction of the tumor mass is genetically modified","volume":"53","author":"Freeman","year":"1993","journal-title":"Cancer Res"},{"key":"key20180107145041_b11-mco-0-0-519","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1073\/pnas.91.10.4348","article-title":"Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors","volume":"91","author":"Barba","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107145041_b12-mco-0-0-519","first-page":"83","article-title":"Prodrug-activated gene therapy: Involvement of an immunological component in the \u2018bystander effect\u2019","volume":"3","author":"Gagandeep","year":"1996","journal-title":"Cancer Gene Ther"},{"key":"key20180107145041_b13-mco-0-0-519","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1053\/hupa.2000.8453","article-title":"Cytopathic effect of in situ gene therapy in prostate cancer","volume":"31","author":"Ayala","year":"2000","journal-title":"Hum Pathol"},{"key":"key20180107145041_b14-mco-0-0-519","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijrobp.2004.01.020","article-title":"Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients","volume":"59","author":"Satoh","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107145041_b15-mco-0-0-519","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<183::AID-IJC8>3.0.CO;2-T","article-title":"Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer","volume":"70","author":"Hall","year":"1997","journal-title":"Int J Cancer"},{"key":"key20180107145041_b16-mco-0-0-519","first-page":"3221","article-title":"Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer","volume":"58","author":"Hall","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107145041_b17-mco-0-0-519","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s003450050185","article-title":"Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer","volume":"18","author":"Hassan","year":"2000","journal-title":"World J Urol"},{"key":"key20180107145041_b18-mco-0-0-519","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.cgt.7700286","article-title":"Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy","volume":"8","author":"Loimas","year":"2001","journal-title":"Cancer Gene Ther"},{"key":"key20180107145041_b19-mco-0-0-519","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<267::AID-IJC23>3.0.CO;2-D","article-title":"Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression","volume":"71","author":"Vile","year":"1997","journal-title":"Int J Cancer"},{"key":"key20180107145041_b20-mco-0-0-519","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1089\/hum.1997.8.15-1807","article-title":"A \u2018distant\u2019 bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor","volume":"8","author":"Kianmanesh","year":"1997","journal-title":"Hum Gene Ther"},{"key":"key20180107145041_b21-mco-0-0-519","first-page":"131","article-title":"The biology of cancer gene therapy","volume":"72","author":"Whartenby","year":"1995","journal-title":"Lab Invest"},{"key":"key20180107145041_b22-mco-0-0-519","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/j.juro.2012.02.878","article-title":"Systemic T-cell activation following neoadjuvant in situ gene therapy in high-risk prostate cancer patients","volume":"187","author":"Satoh","year":"2012","journal-title":"J Urol"},{"key":"key20180107145041_b23-mco-0-0-519","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ymthe.2005.11.022","article-title":"Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer","volume":"13","author":"Ayala","year":"2006","journal-title":"Mol Ther"},{"key":"key20180107145041_b24-mco-0-0-519","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eururo.2005.02.013","article-title":"Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer","volume":"48","author":"van der Linden","year":"2005","journal-title":"Eur Urol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2015.519\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:51:04Z","timestamp":1515336664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2015.519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,2,26]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.3892\/mco.2015.519"],"URL":"https:\/\/doi.org\/10.3892\/mco.2015.519","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}